Ligand Pharmaceuticals Inc
Ligand finances late-stage clinical development programs for biopharmaceutical companies in exchange for royalty interests.
10-QNov 16Latest SEC filing
Nov 13Latest story
November 2026
September 2026
August 2026
July 2026
Ligand finances late-stage clinical development programs for biopharmaceutical companies in exchange for royalty interests.
November 2026
September 2026
August 2026
July 2026